Skip to main content
SpringerLink
Log in

Hypothalamic neuropeptides and memory

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Vasopressin and oxytocin exert pronounced effects on behavior by a direct action on the brain. A single injection of vasopressin results in a long-term inhibition of extinction of a conditioned avoidance response suggesting that vasopressin triggers a long-term effect on the maintenance of a learned response, probably by facilitation of memory processes. In addition vasopressin improves passive avoidance behavior, facilitates retention of sexually motivated T-maze choice behavior in male rats, delays extinction of an appetitive discrimination task, affects approach behavior to an imprinting stimulus in ducklings, delays the postcastration decline in copulatory behavior in male rats, prevents or reverses amnesia induced by electroconvulsive shock, CO2 inhalation, pentylenetetrazol or puromycin. The majority of these effects may be explained by stimulatory influences of vasopressin on memory processes. Generally oxytocin exerts effects which are opposite to those of vasopressin and it has been suggested that oxytocin may be an amnesic neuropeptide.

Evidence has been obtained that endogenous vasopressin and oxytocin play a physiological role in brain processes related to memory.

Various limbic system structures seem to act as the anatomical substrate for the behavioral effects of vasopressin and different neurotransmitter systems seem to be involved. It is postulated that in case vasopressin affects retrieval processes the site of action is located in the amygdala and the dentate gyrus of the hippocampal complex with dopamine and serotonin as the respective neurotransmitter systems involved. In case the behavioral effect is due to changes in storage processes (memory consolidation) the main sites of action include the noradrenaline terminals in the dorsal septum, dorsal raphe and dentate gyrus of the dorsal hippocampus.

Generally the clinical data obtained so far with vasopressin treatment are in agreement with the results from animal experiments and they support the notion on the involvement of vasopressin in memory function. The sometimes reported conflicting results on vasopressin effects in certain patients (Korsakoff or Alzheimer) may have to do with the wide-spread pathology in these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ader, R., De Wied, D., Effects of lysine vasopressin on passive avoidance learning. Psychon. Sci.29 (1972), 46–48.

    Google Scholar 

  2. Anderson, L. T., Bonnet, D. R., Dancis, J., Passive avoidance learning in Lesch-Nyhan disease: effect of 1-desamino-8-arginine-vasopressin. Life Sci.24 (1979), 905–910.

    PubMed  Google Scholar 

  3. Bailey, W. H., Weiss, J. M., Evaluation of a “memory deficit” in vasopressin-deficient rats. Brain Res.162 (1979) 174–178.

    PubMed  Google Scholar 

  4. Blake, D. R., Dood, M. J., Grimley Evans, J., Vasopressin in amnesia. Lancet I (1978), 608.

    Google Scholar 

  5. Bohus, B., Effects of desglycinamide-lysine vasopressin (DG-LVP) on sexually motivated T-maze behavior of the male rat. Horm. Behav.8 (1977), 52–61.

    PubMed  Google Scholar 

  6. Bohus, B., van Wimersma Greidanus, Tj. B., De Wied, D., Behavioral and endocrine responses of rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain). Physiol. Behav.14 (1975), 609–615.

    PubMed  Google Scholar 

  7. Bohus, B., Urban, I., van Wimersma Greidanus, Tj. B., De Wied, D., Opposite effects of oxytocin and vasopressin on avoidance behavior and hippocampal theta rhythm in the rats. Neuropharmacology17 (1978 a), 239–247.

    PubMed  Google Scholar 

  8. Bohus, B., Kovács, G. L., De Wied, D., Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes. Brain Res.157 (1978 b), 414–417.

    PubMed  Google Scholar 

  9. Bohus, B., Conti, L., Kovács, G. L., Versteeg, D. H. G., Modulation of memory processes by neuropeptides: Interaction with neurotransmitter systems. In: Neuronal Plasticity and Memory Formation (Marsan, C. A., Matthies, H., eds.), pp. 75–87. New York: Raven Press.

  10. Bookin, H. B., Pfeifer, W. D., Effect of lysine vasopressin on pentylenetetrazol-induced retrograde amnesia in rats. Pharmac. Biochem. Behav.7 (1977), 51–54.

    Google Scholar 

  11. Brito, G. N. O., Thomas, G. J., Gingold, S. I., Gash, D. M., Behavioral characteristics of vasopressin-deficient rats (Brattleboro strain). Brain Res. Bull.6 (1981), 71–75.

    PubMed  Google Scholar 

  12. Buijs, R. M., Velis, D. N., Swaab, D. F., Extrahypothalamic vasopressin and oxytocin innervation of fetal and adult rat brain. Progr. Brain Res.53 (1980), 159–167.

    Google Scholar 

  13. Celestian, J. F., Carey, R. J., Miller, M., Unimpaired maintenance of a conditioned avoidance response in the rat with diabetes insipidus. Physiol. Behav.15 (1975), 707–711.

    PubMed  Google Scholar 

  14. Delwaide, P. J., Devoitille, J. M., Ylieff, M., Acute effects of drugs upon memory of patients with senile dementia. Acta Psychiatr. Belg.80 (1980), 748–754.

    PubMed  Google Scholar 

  15. De Wied, D., The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of conditioned avoidance response in rats. Int. J. Neuropharmac.4 (1965), 157–167.

    Google Scholar 

  16. De Wied, D., Long-term effect of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature232 (1971), 58–60.

    PubMed  Google Scholar 

  17. De Wied, D., Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments. Life Sci.19 (1976), 685–690.

    PubMed  Google Scholar 

  18. De Wied, D., Bohus, B., Long term and short term effects on retention of a conditioned avoidance response in rats by treatment with long acting pitressin and α-MSH. Nature212 (1966), 1484–1486.

    Google Scholar 

  19. De Wied, D., Gispen, W. H., Impaired development of tolerance to morphine analgesia in rats with hereditary diabetes insipidus. Psychopharmocologie (Berlin)46 (1976), 27–29.

    Google Scholar 

  20. De Wied, D., Gispen, W. H., Behavioral effects of peptides. In: Peptides in Neurobiology (Gainer, H., ed.), pp. 397–448. New York: Plenum Press. 1977.

    Google Scholar 

  21. De Wied, D., Greven, H. M., Lande, S., Witter, A., Dissociation of the behavioral and endocrine effects of lysine vasopressin by tryptic digestion. Br. J. Pharmacol.45 (1972), 118–122.

    PubMed  Google Scholar 

  22. De Wied, D., Bohus, B., van Wimersma Greidanus, Tj. B., The hypothalamic-neurohypophyseal system and preservation of conditioned avoidance behavior in rats. Progr. Brain Res.41 (1974), 417–428.

    Google Scholar 

  23. De Wied, D., Bohus, B., van Wimersma Greidanus, Tj. B., Memory deficit in rats with hereditary diabetes insipidus. Brain Res.85 (1975), 152–156.

    PubMed  Google Scholar 

  24. De Wied, D., van Wimersma Greidanus, Tj. B., Bohus, B., Urban, I., Gispen, W. H., Vasopressin and memory consolidation. Prog. Brain Res.45 (1976), 181–194.

    PubMed  Google Scholar 

  25. Durso, R., Fedio, P., Brouwers, P., Cox, C., Martin, A. J., Ruggieri, S. A., Tamminga, C. A., Chase, T. N., Lysine vasopressin in Alzheimer's disease. Neurology32 (1982), 674–677.

    PubMed  Google Scholar 

  26. Ferrier, B. M., Kennet, D. J., Devlin, M. C., Influence of oxytocin on human memory processes. Life Sci.27 (1980), 2311–2317.

    PubMed  Google Scholar 

  27. Fewtrell, W. D., House, A. O., Jamie, P. F., Oates, M. R., Cooper, J. E., Effects of vasopressin on memory and new learning in a brain-injured population. Psychol. Med.12 (1982), 423–425.

    PubMed  Google Scholar 

  28. Gilot, P., Crabbe, J., Legros, J. J., Bilanz mnésique de cinq subjects présentent un diabète central idiopathique familial. Acta Psychiatr. Belg.80 (1980), 755–761.

    PubMed  Google Scholar 

  29. Hostetter, G., Jubb, S. L., Kozlowski, G. P., Vasopressin affects the behavior of rats in a positively rewarded discrimination task. Life Sci.21 (1977), 1323–1328.

    PubMed  Google Scholar 

  30. Jenkins, J. S., Mather, H. M., Coughlan, A. K., Jenkins, D. G., Desmopressin in post-traumatic amnesia. LancetII (1979), 1245–1246.

    Google Scholar 

  31. Jenkins, J. S., Mather, H. M., Coughlan, A. K., Jenkins, D. G., Desmopressin and Desglycinamide: Vasopressin in posttraumatic amnesia. LancetI (1981), 38–39.

    Google Scholar 

  32. Jenkins, J. S., Mather, H. M., Coughlan, A. K., Effect of desmopressin in normal and impaired memory. J. Neurol. Neurosurg. Psychiatry45 (1982), 830–831.

    PubMed  Google Scholar 

  33. Jolles, J., Vasopressin-like peptides and the treatment of memory disorders in man. Progr. Brain Res.60 (1983), 169–182.

    Google Scholar 

  34. Jolles, J., Gaillard, A. W. K., Hijman, R., Memory disorders and vasopressin. In: Integrative Neurohymoral Mechanism (Endröczi, E., De Wied, D., Angelucci, L., Scapagnini, U., eds.), pp. 63–73. Amsterdam: Elsevier Biomedical Press. 1983.

    Google Scholar 

  35. Kaye, W. H., Weingartner, H., Gold, P., Ebert, M. H., Gillin, J. C., Sitaram, N., Smallberg, S., Cognitive effects of cholinergic and vasopressin-like agents in patients with primary degenerative dementia. In: Alzheimer's Disease: A Report of Progress (Corkin, S.et al., eds.), pp. 433–442. New York: Raven Press. 1982.

    Google Scholar 

  36. Koch-Henriksen, N., Nielsen, H., Vasopressin in post-traumatic amnesia. LancetI (1981), 38–39.

    Google Scholar 

  37. Kovács, G. L., Telegdy, G., Role of oxytocin in memory and amnesia. Pharmacol. Ther.18 (1982), 375–395.

    PubMed  Google Scholar 

  38. Krivoy, W. A., Zimmerman, E., Lande, S., Facilitation of development of resistance to morphine analgesia by desglycinamide9-lysine-vasopressin. Proc. Natl. Acad. Sci. U.S.A.71 (1974), 1852–1856.

    PubMed  Google Scholar 

  39. Láczi, F., Valkusz, Zs., Lászlo, F. A., Wágner, A., Járdánházy, T., Szász, A., Szilárd, J., Telegdy, G., Effects of lysinevasopressin and 1-desamino-8-D-arginine-vasopressin on the memory in healthy individuals and diabetes insipidus patients. Psychoneuroendocrinology7 (1982), 185–193.

    PubMed  Google Scholar 

  40. Láczi, F., Fekete, M., De Wied, D., Antidiuretic activity and immunoreactive arginine-vasopressin levels in eye plexus blood during passive avoidance behaviour in rats. Life Sci.32 (1983 a), 577–589.

    PubMed  Google Scholar 

  41. Láczi, F., Gaffori, O., De Kloet, E. R., De Wied, D., Differential responses in immunoreactive arginine-vasopressin content of micro-dissected regions during passive avoidance behavior. Brain Res.260 (1983b), 342–346.

    PubMed  Google Scholar 

  42. Láczi, F., Gaffori, O., De Kloet, E. R., De Wied, D., Argininevasopressin content of hippocampus and amygdala during passive avoidance behavior in rats. Brain Res.280 (1983 c), 309–315.

    PubMed  Google Scholar 

  43. Láczi, F., Van Ree, J. M., Wágner, A., Valkusz, Zs., Járdánházy, T., Kovács, G. L., Telegdy, G., Szilárd, J., László, F. A., De Wied, D., Effects of desglycinamide-arginine-vasopressin (DGAVP) on memory processes in diabetes insipidus patients and in non-diabetic subjects. Acta Endocrinol.102 (1983 d), 205–212.

    PubMed  Google Scholar 

  44. Láczi, F., Van Ree, J. M., Balogh, L., Szász, A., Járdánházy, T., Wágner, A., Gáspár, L., Valkusz, Z., Dobranovics, I., Szilárd, J., László, F. A., De Wied, D., Lack of effect of desglycinamidearginine-vasopressin (DGAVP) on memory in patients with Korsakoff syndrome. Acta Endocrinol.104 (1983 e), 177–182.

    PubMed  Google Scholar 

  45. Lande, S., Flexner, J. B., Flexner, B., Effect of corticotropin and desglycinamide9-lysine vasopressin on suppression of memory by puromycin. Proc. Natl. Acad. Sci. U.S.A.69 (1972), 558–560.

    PubMed  Google Scholar 

  46. LeBoeuf, A., Lodge, J., Eames, P. G., Vasopressin and memory in Korsakoff syndrome. LancetII (1978), 1370.

    Google Scholar 

  47. Legros, J. J., Gilot, P., Seron, X., Claessens, J., Adam, A., Moeglin, J. M., Audibert, A., Berchier, P., Influence of vasopressin on learning and memory. LancetI (1978), 41–42.

    Google Scholar 

  48. Leshner, A. I., Roche, K. E., Comparison of the effect on ACTH and lysine vasopressin on avoidance-of-attack in mice. Physiol. Behav.18 (1977), 879–883.

    PubMed  Google Scholar 

  49. Leshner, A. I., Hofstein, R., Samuel, D., van Wimersma Greidanus, Tj. B., Intraventricular injection of antivasopressin serum blocks learned helpnessness in rats. Pharmacol. Biochem. Behav.9 (1978), 889–892.

    PubMed  Google Scholar 

  50. Lissak, K., Bohus, B., Pituitary hormones and avoidance behavior of the rat. Int. J. Physiobiol.2 (1972), 103–115.

    Google Scholar 

  51. Martin, J. T., van Wimersma Greidanus, Tj. B., Imprinting behavior: influences of vasopressin and ACTH analogues. Psychoneuroendocrinology3 (1979), 261–269.

    Google Scholar 

  52. Miller, M., Barranca, E. G., Dean, M. C., Brush, F. R., Does the rat with hereditary hypothalamic diabetes insipidus have impaired avoidance learning and/or performance? Pharmacol. Biochem. Behav.5 (1976), 35–40.

    Google Scholar 

  53. Oliveros, J. C., Jandali, M. K., Timsit-Berthier, M., Remy, R., Benghezal, A., Audibert, A., Moeglen, J. M., Vasopressin in amnesia. LancetI (1978), 42.

    Google Scholar 

  54. Pfeifer, W. D., Bookin, H. B., Vasopressin antagonizes retrograde amnesia in rats following electroconvulsive shock. Pharmacol. Biochem. Behav.9 (1978), 261–263.

    PubMed  Google Scholar 

  55. Pittman, Q. J., Rogers, J., Madamba, S., Bloom, F., Deficits in the Brattleboro rats tolerance to ethanol. Ann. N.Y. Acad. Sci.394 (1981), 764–766.

    Google Scholar 

  56. Rigter, H., van Riezen, H., De Wied, D., The effect of ACTH-and vasopressin analogues on CO2-induced retrograde amnesia in rats. Physiol. Behav.13 (1974), 381–388.

    PubMed  Google Scholar 

  57. Schulz, H., Kovács, G. L., Telegdy, G., Effect of physiological doses of vasopressin and oxytocin on avoidance and exploratory behaviour in rats. Acta Physiol. Hung.45 (1974), 211–215.

    Google Scholar 

  58. Sofroniew, M. V., Weindl, A., Central nervous system distribution of vasopressin, oxytocin and neurophysin. In: Endogenous Peptides and Learning and Memory Processes (Martinez, J. L., Jensen, R. A., Messing, R. B., Rigter, H., McGaugh, J. L., eds.), pp. 327–369. New York: Academic Press. 1981.

    Google Scholar 

  59. Strupp, B., Weingartner, H., Goodwin, F. K., Gold, Ph. W., Neurohypophyseal hormones and cognition. Pharmacol. Ther.23 (1984), 267–279.

    Google Scholar 

  60. Timsit-Berthier, M., Mantanus, H., Jacques, M. C., Seron, X., Legros, J. J., Audibert, A., Moeglen, J. M., Utilité de la LVP dans l'amnésie posttraumatique: à propos de 6 observations. Journées de Psychoneuroendocrinologie Clinique, Liège, abstract 46, 1979.

  61. Tinklenberg, J. R., Pfefferbaum, A., Berger, P. A., 1-Desamino-D-arginine-vasopressin in cognitively impaired patients. Psychopharmacol. Bull.17 (1981), 206–207.

    Google Scholar 

  62. Tinklenberg, J. R., Pigache, R., Pfefferbaum, A., Berger, P. A., Vasopressin peptides and dementia. In: Alzheimer's Disease: A Report of Progress (Corkin, S., Davis, K. L., Growdon, J. H., Usdin, E., Wurtman, R. J., eds.), pp. 463–468. New York: Raven Press. 1982.

    Google Scholar 

  63. Urban, I., De Wied, D., Inferior quality of RSA during paradoxical sleep in rats with hereditary diabetes insipidus. Brain Res.97 (1975), 362–366.

    PubMed  Google Scholar 

  64. Urban, I., De Wied, D., Neuropeptides: Effects on paradoxical sleep and theta rhythm in rats. Pharmacol. Biochem. Behav.8 (1978), 51–59.

    PubMed  Google Scholar 

  65. Valtin, H., Hereditary hypothalamic diabetes insipidus in rats (Brattleboro strain). Am. J. Med.42 (1967), 814–827.

    PubMed  Google Scholar 

  66. Valtin, H., Schroeder, H. A., Familial hypothalamic diabetes insipidus in rats (Brattleboro strain). Am. J. Physiol.206 (1964), 425–430.

    PubMed  Google Scholar 

  67. Van Wimersma Greidanus, Tj. B., Disturbed behaviour and memory of the Brattleboro rat. Ann. N.Y. Acad. Sci.394 (1982), 655–662.

    PubMed  Google Scholar 

  68. Van Wimersma Greidanus, Tj. B., De Wied, D., Modulation of passive avoidance behavior of rats by intracerebroventricular administration of antivasopressin serum. Behav. Biol.18 (1976), 325–333.

    PubMed  Google Scholar 

  69. Van Wimersma Greidanus, Tj. B., Wintzen, A. R., Neurohypophyseal hormones and memory function. Int. J. Neurol.14 (1980), 152–161.

    Google Scholar 

  70. Van Wimersma Greidanus, Tj. B., Bohus, B., De Wied, D., Effects of peptide hormones on behavior. In: Progress in Endocrinology, Int. Congress Series No. 273, pp. 197–201. Amsterdam: Excerpta Medica. 1973.

    Google Scholar 

  71. Van Wimersma Greidanus, Tj. B., Dogterom, J., De Wied, D., Intraventricular administration of antivasopressin serum inhibits memory consolidation in rats. Life Sci.16 (1975 a), 637–644.

    PubMed  Google Scholar 

  72. Van Wimersma Greidanus, Tj. B., Bohus, B., De Wied, D., The role of vasopressin in memory processes. Progr. Brain Res.42 (1975 b), 135–141.

    Google Scholar 

  73. Van Wimersma Greidanus, Tj. B., Tjon Kon Fat-Bronstein, H., van Ree, J. M., Antisera to pituitary hormones modulate development of tolerance to morphine. In: Characteristics and Function of Opioids (van Ree, J. M., Terenius, L., eds.), pp. 73–74. Amsterdam: Elsevier/North-Holland Biomedical Press. 1978.

    Google Scholar 

  74. Van Wimersma Greidanus, Tj. B., van Ree, J. M., De Wied, D., Vasopressin and memory. Pharmacol. Ther.20 (1983 a), 437–458.

    PubMed  Google Scholar 

  75. Van Wimersma Greidanus, Tj. B., Bohus, B., Kovács, G. L., Versteeg, D. H. G., Burbach, J. P. H., De Wied, D., Sites of behavioral and neurochemical action of ACTH-like peptides and of neurohypophyseal hormones. Neurosci. Biobehav. Rev.7 (1983b), 453–463.

    PubMed  Google Scholar 

  76. Waggoner, R. W., Slonim, A. E., Armstrong, S. H., Improved psychological status of children under DDAVP treatment for central diabetes insipidus. Am. J. Psychiatry135 (1978), 361–362.

    PubMed  Google Scholar 

  77. Weingartner, H., Kaye, W., Gold, P., Smallberg, S., Peterson, R., Gillin, J. C., Ebert, M., Vasopressin treatment of cognitive dysfunction in progressive dementia. Life Sci.29 (1981 a), 2721–2726.

    PubMed  Google Scholar 

  78. Weingartner, H., Gold, P., Ballenger, J. C., Smallberg, S. A., Summers, R., Rubinow, D. R., Post, R. M., Goodwin, F. K., Effects of vasopressin on human memory functions. Science211 (1981 b), 601–603.

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Tj. B. van Wimersma Greidanus

    Present address: Rudolf Magnus Institute for Pharmacology, Medical Faculty, University of Utrecht, The Netherlands

Authors and Affiliations

  1. Rudolf Magnus Institute for Pharmacology, Medical Faculty, University of Utrecht, The Netherlands

    J. Jolles & D. De Wied

  2. Psychiatric University Clinic, Utrecht, The Netherlands

    J. Jolles

Authors
  1. Tj. B. van Wimersma Greidanus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Jolles
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. De Wied
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Wimersma Greidanus, T.B., Jolles, J. & De Wied, D. Hypothalamic neuropeptides and memory. Acta neurochir 75, 99–105 (1985). https://doi.org/10.1007/BF01406329

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01406329

Keywords

Search

Navigation